Charlie Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charlie Zhong has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Metayer
Division of Epidemiology, School of Public Health University of California Berkeley California USA
20 shared publications - Joseph L. Wiemels
Center for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, USA
20 shared publications - W. James Gauderman
Division of Biostatistics, Department of Population and Public Health Sciences, University of Southern California
20 shared publications - Xiaomei Ma
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT
20 shared publications - Nicholas Mancuso
Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California
17 shared publications - Xinran Wang
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
17 shared publications
Latest Publications
- 14 November 2026
- Published by Elsevier in Annals of Epidemiology
Using hip-worn accelerometer non-wear time to assess sleep duration and sleep midpoint
- 14 November 2026
- Published by Elsevier in Annals of Epidemiology
Using hip-worn accelerometer non-wear time to assess sleep duration and sleep midpoint
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Figure S1. Cubic spline model of association between nocturia and bladder cancer among smokers
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Figure S1. Cubic spline model of association between nocturia and bladder cancer among smokers
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S1. Demographic comparison of male Cancer Prevention Study II Nutrition Cohort respondents and non-respondents to the 1997 follow-up questionnaire
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S1. Demographic comparison of male Cancer Prevention Study II Nutrition Cohort respondents and non-respondents to the 1997 follow-up questionnaire
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S2. Fully adjusted lag models for the association between nocturia and bladder cancer risk
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S2. Fully adjusted lag models for the association between nocturia and bladder cancer risk
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Data from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Background:It is believed that contact of the urothelial lining to carcinogens induces mutations that lead to cancer. Nocturia, waking up at night to urinate, may void carcinogens and reduce the risk of bladder cancer. Methods:The Cancer Prevention Study II Nutrition Cohort is a prospective study of cancer incidence that enrolled participants in 1992 with biennial follow-up beginning in 1997. Cases were ascertained through state cancer registry, medical record verification, or death certificate. Cox models were used to calculate hazard ratios (HR) and 95% confidence intervals (95% CI) for the association between nocturia and primary incident bladder cancer. Results:Among 49,767 males, 2,655 reported being current smokers in 1997 (30,559 former smokers). There were 1,207 bladder cancers over 210 million person-years of follow-up. Adjusting for demographic and health factors, nocturia once per night was associated with a 46% decreased risk of bladder cancer among smokers (HR1/night, 0.54; 95% CI, 0.30–0.95; HR2+/night, 0.90; 95% CI, 0.52–1.57). We observed no association among nonsmokers (HR1/night, 1.10; 95% CI, 0.72–1.69; HR2+/night, 1.17; 95% CI, 0.75–1.81) or former smokers (HR1/night, 1.17; 95% CI, 0.92–1.49; HR2+/night, 1.12; 95% CI, 0.87–1.43). Our main findings were no longer statistically significant in 2-year (HR, 0.58; 95% CI, 0.31–1.09) and 5-year lag models (HR, 0.80; 95% CI, 0.32–1.99). Conclusions:Only nocturia once per night was associated with a lower risk of bladder cancer in current smokers; however, associations were attenuated in lag analyses and no dose–response relationship was observed. Impact:Nocturia may reduce the risk of bladder cancer among smokers. Further work is needed to confirm findings and understand mechanisms.
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Background:It is believed that contact of the urothelial lining to carcinogens induces mutations that lead to cancer. Nocturia, waking up at night to urinate, may void carcinogens and reduce the risk of bladder cancer. Methods:The Cancer Prevention Study II Nutrition Cohort is a prospective study of cancer incidence that enrolled participants in 1992 with biennial follow-up beginning in 1997. Cases were ascertained through state cancer registry, medical record verification, or death certificate. Cox models were used to calculate hazard ratios (HR) and 95% confidence intervals (95% CI) for the association between nocturia and primary incident bladder cancer. Results:Among 49,767 males, 2,655 reported being current smokers in 1997 (30,559 former smokers). There were 1,207 bladder cancers over 210 million person-years of follow-up. Adjusting for demographic and health factors, nocturia once per night was associated with a 46% decreased risk of bladder cancer among smokers (HR1/night, 0.54; 95% CI, 0.30–0.95; HR2+/night, 0.90; 95% CI, 0.52–1.57). We observed no association among nonsmokers (HR1/night, 1.10; 95% CI, 0.72–1.69; HR2+/night, 1.17; 95% CI, 0.75–1.81) or former smokers (HR1/night, 1.17; 95% CI, 0.92–1.49; HR2+/night, 1.12; 95% CI, 0.87–1.43). Our main findings were no longer statistically significant in 2-year (HR, 0.58; 95% CI, 0.31–1.09) and 5-year lag models (HR, 0.80; 95% CI, 0.32–1.99). Conclusions:Only nocturia once per night was associated with a lower risk of bladder cancer in current smokers; however, associations were attenuated in lag analyses and no dose–response relationship was observed. Impact:Nocturia may reduce the risk of bladder cancer among smokers. Further work is needed to confirm findings and understand mechanisms.
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S3. Fully adjusted models for the association between nocturia and bladder cancer risk among participants with fluid intake, assessed in 1999
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S3. Fully adjusted models for the association between nocturia and bladder cancer risk among participants with fluid intake, assessed in 1999
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S4. Fully adjusted models for the association between nocturia and bladder cancer risk stratified by tumor stage
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Risk of Bladder Cancer among Male Participants Reporting Nocturia in the Cancer Prevention Study II
Supplementary Table S4. Fully adjusted models for the association between nocturia and bladder cancer risk stratified by tumor stage
- Open Access
- 9 September 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1) , 1077
Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines
In the article titled “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,41
- 9 September 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1) , 1077
Open AccessComment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines
In the article titled “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,41
- 25 August 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (8) , e70588
The Impact of a Physical Activity Intervention on Cognitive and Mental Health Outcomes in Cancer Survivors
Objective: Physical activity (PA) is a safe, effective non‐pharmacological method for reducing many adverse symptoms among cancer survivors. However, evidence supporting the benefits of digital PA interventions on cognitive function, anxiety, and depression among survivors is inconsistent, with very few examining the fear of cancer recurrence (FCR). This trial with a cohort study aimed to examine the impact of a one‐year digital PA intervention on changes in cognitive and mental health outcomes among cancer survivors. Methods: 415 participants were randomized 2:1 to an interactive PA website or flexibility control website. Anxiety, depression, FCR, and perceived cognitive function measured at baseline and at three‐, six‐, and 12‐month follow‐ups were analyzed using linear mixed models adjusted for age. Two post‐hoc analyses were performed: (1) stratified by compliance with website protocol and (2) excluding participants at baseline with low anxiety, depression, or FCR, or high cognitive functioning. Results: 94% of participants included in this analysis were women ( n = 368) with a mean age of 62 years (SD = 8.5). In intent‐to‐treat models, the intervention was not effective in improving depression, anxiety, cognitive function, or FCR; however, among participants with high baseline FCR, engaging with the PA website intervention led to a significant reduction in FCR throughout the trial duration (compliant: 19.2 [16.8–21.6] at month 12 compared to 23.8 [21.3–26.2] at baseline). Conclusions: Overall, the intervention showed no meaningful effects on depression, anxiety, or perceived cognitive function. Post‐hoc findings suggested reduced FCR among compliant survivors with elevated baseline FCR, warranting prospective validation. Trial registration: This trial was registered on ClinicalTrials.gov (NCT05356988)
- 25 August 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (8) , e70588
The Impact of a Physical Activity Intervention on Cognitive and Mental Health Outcomes in Cancer Survivors
Objective: Physical activity (PA) is a safe, effective non‐pharmacological method for reducing many adverse symptoms among cancer survivors. However, evidence supporting the benefits of digital PA interventions on cognitive function, anxiety, and depression among survivors is inconsistent, with very few examining the fear of cancer recurrence (FCR). This trial with a cohort study aimed to examine the impact of a one‐year digital PA intervention on changes in cognitive and mental health outcomes among cancer survivors. Methods: 415 participants were randomized 2:1 to an interactive PA website or flexibility control website. Anxiety, depression, FCR, and perceived cognitive function measured at baseline and at three‐, six‐, and 12‐month follow‐ups were analyzed using linear mixed models adjusted for age. Two post‐hoc analyses were performed: (1) stratified by compliance with website protocol and (2) excluding participants at baseline with low anxiety, depression, or FCR, or high cognitive functioning. Results: 94% of participants included in this analysis were women ( n = 368) with a mean age of 62 years (SD = 8.5). In intent‐to‐treat models, the intervention was not effective in improving depression, anxiety, cognitive function, or FCR; however, among participants with high baseline FCR, engaging with the PA website intervention led to a significant reduction in FCR throughout the trial duration (compliant: 19.2 [16.8–21.6] at month 12 compared to 23.8 [21.3–26.2] at baseline). Conclusions: Overall, the intervention showed no meaningful effects on depression, anxiety, or perceived cognitive function. Post‐hoc findings suggested reduced FCR among compliant survivors with elevated baseline FCR, warranting prospective validation. Trial registration: This trial was registered on ClinicalTrials.gov (NCT05356988)